Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05796141 · ClinicalTrials.gov registry record · NA
Becoming United in Lifestyle Decisions
A NA study of Overweight and Obesity, sponsored by University of Connecticut.
- Recruiting
- Registry status
- NA
- Development phase
- 736
- Enrollment target
- 1
- Study location
NCT05796141: Recruiting NA study of Overweight and Obesity, sponsored by University of Connecticut.
NCT05796141 is a NA study of Overweight and Obesity that is actively recruiting participants, run by University of Connecticut. The registered enrollment target is 736 participants, above the 222-participant average among 115 other Overweight and Obesity trials with a reported enrollment target (232% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05796141, a NA study of Overweight and Obesity, is actively recruiting participants, sponsored by University of Connecticut.
- RECRUITING
- Registry status
- NA
- Development phase
- 736 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this project is to investigate how to enhance the effects of an online-only (mHealth) couples weight loss program. This study will use an innovative methodological framework, the Multiphase Optimization Strategy (MOST), to test four different strategies for weight loss and partner support in addition to a core intervention (i.e., dyadic action planning, joint feedback on goal progress, autonomy support training, and home environment modifications).
Primary Outcome
Weight change from baseline to 6 months. Weight will be objectively measured on a digital scale in the participant's home and weight change will be calculated.
Conditions Studied
Interventions
- BEHAVIORAL Core Behavioral Weight Loss (BWL) intervention
- BEHAVIORAL Dyadic Action Planning
- BEHAVIORAL Joint Feedback
- BEHAVIORAL Autonomy Support Training
- BEHAVIORAL Home Environment Modifications
Study Locations (1)
Connecticut
- UConn's Weight Management Research Group - Hartford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 736 participants |
| Start Date | 2024-03-13 |
| Est. Completion | 2026-11 |
| Phase | NA |
What NCT05796141 shows while recruiting
NCT05796141 is an interventional study that assigns participants to a tested intervention. The registered 736 participants enrollment target is mid-sized for trials with a published cap, above the 222-participant average among 115 other Overweight and Obesity trials with a reported enrollment target (232% higher).
The record links to 1 condition, with Overweight and Obesity appearing as the primary indexed condition, and to 5 interventions - of which Core Behavioral Weight Loss (BWL) intervention is the first listed.
NCT05796141 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT05796141 about?
NCT05796141 is a clinical study titled "Becoming United in Lifestyle Decisions". The goal of this project is to investigate how to enhance the effects of an online-only (mHealth) couples weight loss program. This study will use an innovative methodological framework, the Multiphase Optimization Strategy (MOST), to test four different strategies for weight loss and partner suppor...
What is the current status of trial NCT05796141?
This trial is currently recruiting. It is a NA study. The enrollment target is 736 participants. The study started on 2024-03-13. Estimated completion is 2026-11.
What conditions does trial NCT05796141 study?
This clinical trial studies the following conditions: Overweight and Obesity.
What interventions are being tested in trial NCT05796141?
The interventions under investigation include: Core Behavioral Weight Loss (BWL) intervention (BEHAVIORAL), Dyadic Action Planning (BEHAVIORAL), Joint Feedback (BEHAVIORAL), Autonomy Support Training (BEHAVIORAL), Home Environment Modifications (BEHAVIORAL).
Who is sponsoring clinical trial NCT05796141?
This trial is sponsored by University of Connecticut, which has 107 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05796141 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Overweight and Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05796141's enrollment target sits among peer trials
736 7th of 115 higher than 109 of 115 other Overweight and Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Overweight and Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Dose Response Effects of Pecan Consumption
RECRUITING · NA
-
A Pilot Factorial Trial of an Integrated Lifestyle Intervention
RECRUITING · NA
-
Cottonseed Oil Dose Response
RECRUITING · NA
-
Cooking Skills to Improve Long-Term Weight Loss in Young Adults With Intellectual Disabilities
RECRUITING · NA
-
Testing the Adipose Expandability Hypothesis in Vivo During Overfeeding
RECRUITING · NA
-
Cottonseed Oil Versus Matched PUFA Effects
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05947851 · 735 participants · Phase 3
A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).
- NCT05999084 · 735 participants
Georgia Memory Net Anti-Amyloid Monoclonal Antibody Registry
- NCT06825689 · 735 participants · NA
Unidos Contra el VPH
- NCT06216301 · 734 participants · Phase 3
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI